Lobbying activity

Q1

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Manufacturing, Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q1

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · House · Senate

Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code

View → Q1

AVENUE SOLUTIONS for ALLIANCE FOR REGENERATIVE MEDICINE

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · Senate · $50,000.00 income

Medicare/Medicaid

View → Q1

THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $50,000.00 income

Health Issues

View → Q1

THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $40,000.00 income

Pharmacy

View → Q1

THE KPM GROUP DC LLC for ASTRIA THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $40,000.00 income

Pharmacy

View → Q1

PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate

Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

NOVARTIS for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q1

AKIN GUMP STRAUSS HAUER & FELD for BIOTECHNOLOGY INNOVATION ORGANIZATION

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Health Issues

View → Q1

EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Health Issues

View → Q1

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate

Health Issues, Taxation/Internal Revenue Code, Tobacco, Budget/Appropriations

View → Q1

ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

TIBER CREEK GROUP for ACADIA PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $80,000.00 income

Health Issues, Taxation/Internal Revenue Code

View → Q1

ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate

Health Issues, Medicare/Medicaid

View → Q1

LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $10,000.00 income

Health Issues

View → Q1

BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate

Pharmacy

View → Q1

ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

ASSOCIATION FOR CLINICAL ONCOLOGY for ASSOCIATION FOR CLINICAL ONCOLOGY

1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate

Medicare/Medicaid, Health Issues, Tobacco, Budget/Appropriations

View → Q1

MEHLMAN CONSULTING, INC. for ULTRAGENYX PHARMACEUTICAL, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income

Health Issues

View → Q1

IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate

Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs

View → Q1

TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate

Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid

View → Q1

HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate

Health Issues

View →